These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22508972)

  • 1. The NICE Medical Technologies Evaluation Programme (MTEP): manufacturer submission challenges.
    Sprange K; Clift M
    J R Soc Med; 2012 Apr; 105 Suppl 1(Suppl 1):S4-11. PubMed ID: 22508972
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
    Alshreef A; Jenks M; Green W; Dixon S
    Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences of new product development in the medical device industry.
    Dixon D; Brown A; Meenan BJ; Eatock J
    Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thematic analysis of the strengths and weaknesses of manufacturers' submissions to the NICE Single Technology Assessment (STA) process.
    Carroll C; Kaltenthaler E; FitzGerald P; Boland A; Dickson R
    Health Policy; 2011 Oct; 102(2-3):136-44. PubMed ID: 21763025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs: relevance to medical technology innovation?
    McCarthy AD; Sproson L; Wells O; Tindale W
    J Med Eng Technol; 2014; 39(7):382-7. PubMed ID: 26415684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Technology Assessment in the UK.
    Raftery J; Powell J
    Lancet; 2013 Oct; 382(9900):1278-85. PubMed ID: 24120204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institute for Health and Clinical Excellence: the Medical Technologies Evaluation Programme.
    J Med Eng Technol; 2011 Jul; 35(5):283-4. PubMed ID: 21635177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primer on the assessment of medical technologies.
    Matuszewski KA
    Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adopting medical technologies and diagnostics recommended by NICE: the Health Technologies Adoption Programme.
    Chisholm S
    Ann R Coll Surg Engl; 2014 Jul; 96(5):400-1. PubMed ID: 24992441
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical technology management in U.S. hospitals.
    Baretich MF
    Biomed Sci Instrum; 2002; 38():273-5. PubMed ID: 12085615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Views of Directors of Public Health about NICE Appraisal Guidance: results of a postal survey. National Institute for Clinical Excellence.
    Davies E; Littlejohns P
    J Public Health Med; 2002 Dec; 24(4):319-25. PubMed ID: 12546211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation Programme.
    Green W; Hutton J
    Eur J Health Econ; 2014 Jun; 15(5):449-52. PubMed ID: 24212358
    [No Abstract]   [Full Text] [Related]  

  • 16. NICE Health Technology Appraisal Programme.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16884603
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance.
    Crispi F; Naci H; Barkauskaite E; Osipenko L; Mossialos E
    Appl Health Econ Health Policy; 2019 Apr; 17(2):189-211. PubMed ID: 30367349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment. Evaluation of biomedical innovative technologies.
    Turchetti G; Spadoni E; Geisler EE
    IEEE Eng Med Biol Mag; 2010; 29(3):70-6. PubMed ID: 20659860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the appraisal function of the National Institute for Clinical Excellence (NICE).
    Buxton M
    Value Health; 2001; 4(3):212-6. PubMed ID: 11705183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston Scientific scores. Dollar 27 billion dealfor Guidant moves it into new sector.
    Becker C
    Mod Healthc; 2006 Jan; 36(5):17. PubMed ID: 16479778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.